We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
-13.72%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.35B
AUM Growth
-$2.4B
Cap. Flow
-$757M
Cap. Flow %
-8.1%
Top 10 Hldgs %
23.15%
Holding
300
New
33
Increased
109
Reduced
94
Closed
43

Top Buys

Rank Stock Value
1
DHR icon
Danaher
DHR
+$66.5M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$62.4M
3
TMO icon
Thermo Fisher Scientific
TMO
+$53.8M
4
ANET icon
Arista Networks
ANET
+$47M
5
BSX icon
Boston Scientific
BSX
+$45.3M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$112M
2
AMGN icon
Amgen
AMGN
+$102M
3
AAPL icon
Apple
AAPL
+$102M
4
ATVI
Activision Blizzard
ATVI
+$72.8M
5
FLEX icon
Flex
FLEX
+$70.4M

Sector Composition

Rank Sector Weight
1 Technology 25.47%
2 Financials 23.51%
3 Healthcare 21.25%
4 Communication Services 7.66%
5 Consumer Discretionary 6.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SMTC icon
201
Semtech
SMTC
$10.3B
$5.11M 0.05%
+111,397
New +$5.3M
NTB icon
202
Bank of N.T. Butterfield & Son
NTB
$2.38B
$5.01M 0.05%
+159,964
New +$6.56M
GWPH
203
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$4.87M 0.05%
+50,000
New +$6.56M
PPBI
204
DELISTED
Pacific Premier Bancorp
PPBI
$4.81M 0.05%
188,340
+19,766
+12% +$597K
CAT icon
205
Caterpillar
CAT
$385B
$4.61M 0.05%
36,253
+5,261
+17% +$684K
EWBC icon
206
East-West Bancorp
EWBC
$17.9B
$4.45M 0.05%
102,245
+5,798
+6% +$301K
SIVB
207
DELISTED
SVB Financial Group
SIVB
$4.21M 0.05%
22,141
-1,034
-4% -$253K
TRHC
208
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$3.95M 0.04%
+62,004
New +$4.39M
NMFC icon
209
New Mountain Finance
NMFC
$654M
$3.9M 0.04%
310,000
– –
TWTR
210
DELISTED
Twitter, Inc.
TWTR
$3.69M 0.04%
128,243
+46,243
+56% +$1.45M
HSDT icon
211
Solana Company
HSDT
$94.6M
– –
0
– –
AERI
212
DELISTED
Aerie Pharmaceuticals
AERI
$3.61M 0.04%
100,000
-25,000
-20% -$1.17M
ZLAB icon
213
Zai Lab
ZLAB
$2.14B
$3.48M 0.04%
+150,000
New +$2.78M
TEAM icon
214
Atlassian
TEAM
$25B
$3.03M 0.03%
34,057
-33,359
-49% -$2.64M
GBDC icon
215
Golub Capital BDC
GBDC
$3.37B
$2.89M 0.03%
178,675
-50,401
-22% -$897K
SAGE
216
DELISTED
Sage Therapeutics
SAGE
$2.87M 0.03%
30,000
-5,000
-14% -$572K
PRNB
217
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$2.74M 0.03%
100,000
– –
HDB icon
218
HDFC Bank
HDB
$121B
$2.69M 0.03%
103,792
-1,628
-2% -$38.5K
COHR
219
DELISTED
Coherent Inc
COHR
$2.44M 0.03%
+23,075
New +$2.96M
QTTB icon
220
Q32 Bio
QTTB
$455M
$2.24M 0.02%
+5,556
New +$2.1M
OBSV
221
DELISTED
ObsEva SA Ordinary Shares
OBSV
$2.22M 0.02%
175,000
+25,000
+17% +$372K
KVHI icon
222
KVH Industries
KVHI
$177M
$2.2M 0.02%
213,695
-302
-0.1% -$3.45K
APH icon
223
Amphenol
APH
$173B
$1.92M 0.02%
94,588
-1,130,964
-92% -$24.3M
REPL icon
224
Replimune Group
REPL
$491M
$1.75M 0.02%
175,000
+25,000
+17% +$338K
PRQR icon
225
ProQR Therapeutics
PRQR
$241M
$1.58M 0.02%
100,000
– –
7 8
9
10 11

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q4 2018 Portfolio in Review

As of Q4 2018, Polar Capital held 300 positions worth $9.35B, down 20% from $11.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Polar Capital withdrew a net $757M in Q4 2018, closing 43 positions and reducing 94 holdings. Its most notable exit was Activision Blizzard, an estimated $72.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Polar Capital opened a new position in Boston Scientific worth $44.2M.

  • Polar Capital's largest Q4 2018 buy was Boston Scientific: 1,250,000 shares worth $44.2M.
  • Polar Capital added most to Danaher in Q4 2018, an estimated $66.5M increase.
  • Polar Capital's biggest Q4 2018 reduction was Merck, cutting an estimated $112M.
  • Polar Capital fully exited Activision Blizzard in Q4 2018, selling an estimated $72.8M.
  • Polar Capital's ten largest holdings make up 23% of its $9.35B portfolio in Q4 2018.
  • Polar Capital opened 33 new positions and closed 43 in Q4 2018.
  • Polar Capital's portfolio value fell 20% quarter-over-quarter to $9.35B.

Based on Polar Capital's 13F filing for Q4 2018, filed 14 Feb 2019.